CAS: 462-10-2; 4,4'-Disulfanediylbis(2-Aminobutanoic Acid)

该化合物是一种含有硫的氨基酸,是同细胞steine的二极分,是两种同细胞细胞分子通过分硫化结合而成的.它被归类为一种非蛋白性氨基酸,并参与各种代谢过程,特别是含硫氨基酸的新陈代谢过程.同细胞素通常在身体中发现少量,并且与甲基苯基新陈代谢有关.血液中同细胞素的升高水平可以表明某些健康状况,包括心血管疾病和同细胞素,这是一种遗传疾病,影响同细胞素的代谢.化合物在水中溶解,熔点相对较高.它的结构包括一个与氨基酸混合物的中央碳原子结合,一个碳箱基组,以及一个含有硫醇组的侧链,该组负责其再活性.同细胞素在生物系统中的作用及其在健康中的潜在影响,因此它成为临床和生物化学研究的对象.

结构式图片

相似化合物

6027-15-2 626-72-2 113132-85-7

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号1017-76-1 s-benzyl-dl-hom... | CAS号10593-85-8 (S)-3-AMINODIHY... | CAS号454-29-5 DL-高半胱氨酸 | CAS号504-33-6 DL-高磺基丙氨酸 | CAS号123-41-1 胆碱 | CAS号62-49-7 胆碱 | CAS号60175-95-3 奥莫司坦

合成工艺路线路线简述

    Dl-高半胱氨酸置于高氯酸,Sodium Perchlorate,Fac-[pt(Dach)Cl3(oc(=o)Ch3)].35Hcl,Sodium Chloride体系中,用 水 作为反应溶剂,化学反应 0.08H,反应生成 L-高胱氨酸
    参考文献:生物硫醇化合物还原不对称 Pt(Iv) 前药 Fac-[pt(Dach)Cl3(oc(=o)Ch3)]:动力学和机械特性
    标题:生物硫醇化合物还原不对称 Pt(Iv) 前药 Fac-[pt(Dach)Cl3(oc(=o)Ch3)]:动力学和机械特性
    摘要:合成了不对称 Pt(Iv) 前药fac-[pt (Dach)Cl 3 (oc(=o)Ch 3)] (Dach = 1,2-二氨基环己烷),并将 Pt(Iv) 前药还原了三个生物硫醇谷胱甘肽 (Gsh),半胱氨酸 (Cys) 和同型半胱氨酸 (Hcy) 通过停流光谱仪进行研究.所有还原之后是整体二级反应,在 [pt(Iv)] 和 [硫醇] 中均发生一级反应.pt(Iv) 前药的还原通过氯桥 (Pt-Cl-S) 介导的两个电子转移过程发生.因此,配位的氯化物比来自pt(Iv) 前药的配位-Ch 3 Coo-的氧原子具有更好的架桥效应.k' Cys的反应趋势 > K' Gsh > K' Hcy被发现,说明在 Ph 7.4 缓冲液中反应性遵循 Cys > Gsh > Hcy 的趋势. 图形概要 过渡态在铂 (Iv) 络合物的轴向配位氯化物与来自 Cys/hcy/gsh 的硫醇/硫醇盐基团的硫原子之间形成.
    DOI:10.1007/s11243-021-00480-6

    海关参考信息

    专利信息


    专利号:US-2023037284-A9
    优先权日:2018-11-30
    标题:Combination therapy of peptidomimetic macrocycles
    发明人:GUERLAVAIS VINCENT; ANNIS DAVID ALLEN
    权利人:AILERON THERAPEUTICS INC
    摘要:The present disclosure describes the synthesis of peptidomimetic macrocycles and methods of using peptidomimetic macrocycles to treat a condition. The present disclosure also describes methods of using peptidomimetic macrocycles in combination with at least one additional pharmaceutically-active agent for the treatment of a condition, for example, cancer.

    专利号:US-2025084410-A1
    优先权日:2015-01-12
    标 题:Incorporation of unnatural nucleotides and methods thereof
    发明人:PTACIN JEROD; MALYSHEV DENIS A; CAFFARO CAROLINA E
    权利人:SYNTHORX INC
    摘要:Disclosed herein are methods, compositions and kits for the synthesis of proteins which comprises unnatural amino acids that utilize a mutant tRNA.

    专利号:US-2004053999-A1
    优先权日:1997-09-17
    标题 :Novel compounds and methods for synthesis and therapy
    发明人:BISCHOFBERGER NORBERT W; DAHL TERRENCE C; HITCHCOCK MICHAEL J M; KIM CHOUNG U; LEW WILLARD; LIU HONGTAO; MILLS ROGER G; WILLIAMS MATTHEW A
    摘要:Novel compounds are described. The compounds generally comprise an acidic group, a basic group, a substituted amino or N-acyl and a group having an optionally hydroxylated alkane moiety. Pharmaceutical compositions comprising the inhibitors of the invention are also described. Methods of inhibiting neuraminidase in samples suspected of containing neuraminidase are also described. Antigenic materials, polymers, antibodies, conjugates of the compounds of the invention with labels, and assay methods for detecting neuraminidase activity are also described.

    专利号:US-2018371021-A1
    优先权日:2017-05-11
    标 题 :Peptidomimetic macrocycles and uses thereof
    发明人:AIVADO MANUEL; GUERLAVAIS VINCENT; OLSON KAREN
    权利人:AILERON THERAPEUTICS INC
    摘要:The present disclosure describes the synthesis of peptidomimetic macrocycles and methods of using peptidomimetic macrocycles to treat a condition. The present disclosure also describes methods of using peptidomimetic macrocycles in combination with at least one additional pharmaceutically-active agent for the treatment of a condition, for example, cancer.

    专利号:US-6225341-B1
    优先权日:1995-02-27
    标 题:Compounds and methods for synthesis and therapy
    发明人:BISCHOFBERGER NORBERT W; KIM CHOUNG U; LEW WILLARD; LIU HONGTAO; WILLIAMS MATTHEW A
    权利人:GILEAD SCIENCES INC
    摘要:Novel compounds are described. The compounds generally comprise an acidic group, a basic group, a substituted amino or N-acyl and a group having an optionally hydroxylated alkane moiety. Pharmaceutical compositions comprising the inhibitors of the invention are also described. Methods of inhibiting neuraminidase in samples suspected of containing neuraminidase are also described. Antigenic materials, polymers, antibodies, conjugates of the compounds of the invention with labels, and assay methods for detecting neuraminidase activity are also described.

    专利号:US-9469850-B2
    优先权日:2007-01-18
    标 题 :Oligosaccharides comprising an aminooxy group and conjugates thereof
    发明人:ZHU YUNXIANG; CHENG SENG H; JIANG CANWEN; AVILA LUIS Z
    权利人:GENZYME CORP
    摘要:The invention provides methods for the synthesis of oligosaccharides comprising an aminooxy group. The invention further provides oligosaccharides comprising an aminooxy group, methods for coupling oligosaccharides comprising an aminooxy group to glycoproteins, and oligosaccharide-protein conjugates. Also provided are methods of treating a lysosomal storage disorder in a mammal by administration of an oligosaccharide-protein conjugate.
    新乡市珺隆生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.junlongbio.com
    电话:13525059581👤
    📞 新乡市珺隆生物科技有限公司⚠️参考联系方式

    电话: 13525059581
    邮件:sales@junlongbio.com
    网址: http://www.junlongbio.com
    地址:河南省新乡市红旗区黄河大道5号
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    河南省新乡市红旗区黄河大道5号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别. 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Petrov AI, Dergachev VD. Palladium(II) Ion Mediated Disulfide/Thiolate Interconversion: Predicting the Disulfide Group State from First Principles. J Phys Chem A. 2019 Jun 13;123(23):4873-4882. doi: 10.1021/acs.jpca.9b00740. Epub 2019 May 30. 188(6):778-85. doi: 10.1016/j.amjsurg.2004.08.061. 131(4):1302-8. doi: 10.1093/jn/131.4.1302. 14(6):1237-40. doi: 10.1093/carcin/14.6.1237. 122(3):482-7. doi: 10.1093/jn/122.3.482. 11(2):273-81. doi: 10.1093/carcin/11.2.273. 52(5):823-30. Japanese. 155(1):160-6. doi: 10.1016/s0006-291x(88)81063-5. 25(1):29-37. doi: 10.1002/jobm.3620250109. 4(12):1619-29. doi: 10.1093/carcin/4.12.1619. 43(11):5210-6. 48(3):565-70. doi: 10.1079/bjn19820141. 60(1):204-14. doi: 10.3382/ps.0600204. 59(5):1073-81. doi: 10.3382/ps.0591073. 11(1):14-9. doi: 10.1007/BF02615317. 44(2):286-91. doi: 10.1139/o66-033. 85(6):1339-45. doi: 10.1128/jb.85.6.1339-1345.1963.
    18: LANKFORD CE, RODE LJ, SCHUHARDT VT. Effect of methionine upon utilization of DL-homocystine by Brucella suis. Proc Soc Exp Biol Med. 1952 Aug- Sep;80(4):727-31. doi: 10.3181/00379727-80-19744.

    合成参考文献


    参考文献:10.1016/j.braindev.2011.05.014
    摘要:Prasad AN, Rupar CA, Prasad C. Methylenetetrahydrofolate reductase (MTHFR) deficiency and infantile epilepsy. Brain Dev. 2011 Oct;33(9):758–69. doi: 10.1016/j.braindev.2011.05.014.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知